As of 2025-09-16, the Fair Value of United Therapeutics Corp (UTHR) is 686.55 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 403.11 USD, the upside of United Therapeutics Corp is 70.31%.
With the market price of 403.11 USD and our fair value calculation, United Therapeutics Corp (UTHR) is a good investment. Investing in UTHR stocks now will result in a potential gain of 70.31%.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 514.80 | 475.80 | 727.30 | 984.80 | 1,195.10 | 779.56 |
| YoY growth | 592.63% | -7.58% | 52.86% | 35.40% | 21.35% | 138.93% |
| Market Cap (mil) | 18,232.67 |
| P/E | 14.68x |
| Forward P/E | 14.04x |
| EPS | 27.46 |
| Avg earnings growth rate | 138.93% |
| TTM earnings | 1,242.10 |